Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
Volume: 34, Issue: 12, Pages: 2057 - 2065
Published: Jul 10, 2018
Abstract
Erythropoietin (EPO) has been reported as a novel determinant of fibroblast growth factor 23 (FGF23) production; however, it is unknown whether FGF23 is stimulated by chronic exposure to EPO or by EPO administration in nonpolycystic chronic kidney disease (CKD) models.We analyzed the effects of chronic EPO on FGF23 in murine models with chronically high EPO levels and normal kidney function. We studied the effects of exogenous EPO on FGF23 in...
Paper Details
Title
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
Published Date
Jul 10, 2018
Volume
34
Issue
12
Pages
2057 - 2065
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History